Drug intelligence / Profile preview

JYNNEOS (Bavarian Nordic)

Development stage
Approved
Lead developer
Bavarian Nordic
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal
01

Overview

JYNNEOS is a live, non-replicating vaccine developed by Bavarian Nordic for the prevention of smallpox and mpox (monkeypox). It is based on the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) strain, a highly attenuated orthopoxvirus that cannot replicate in human cells. This non-replicating profile provides a significantly improved safety profile compared to traditional replicating smallpox vaccines like ACAM2000, making it suitable for immunocompromised individuals and those with atopic dermatitis. The vaccine works by stimulating both humoral (neutralizing antibodies) and cellular (T-cell) immune responses against orthopoxviruses, providing cross-protection against multiple viruses within the genus.

Brand names
JYNNEOSIMVANEXIMVAMUNE
Other names
Modified Vaccinia Ankara-Bavarian NordicMVA-BN vaccinesmallpox and monkeypox vaccine

Beyond the preview

Go deeper on JYNNEOS (Bavarian Nordic).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JYNNEOS (Bavarian Nordic).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call